跳至主要内容
临床试验/IRCT20200408046990N4
IRCT20200408046990N4招募中3 期

Evaluation of the effect of oral formulation prepared from extract of pomegranate for treatment of benign prostate hyperplasia: A triple blind randomized clinical trial

Mashhad University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
50 years 至 80 years(—)
性别
Male

入选标准

  • age between 50-80 years
  • Mild to moderate clinical diagnisis of BPH (patient has lower urinary (based on international prostate symptom score (IPSS)<18)

排除标准

  • simultaneous use of BPH medications except tamsulosin
  • use of supplements which existing in BPH such as saw palmetto , vitamin E and Quercetin vitamins
  • having prostate or bladder cancer
  • history of prostate surgery
  • PSA>4mg/ml
  • Post void residue (PVR)=200 ml
  • history of allergy to pomegranate and its derivatives
  • use of medications with considerable metabolism through Cytochrome 3A4

研究者

相似试验

Evaluation of the effect of oral formulation... | 临床试验